Cargando…
Minor Variant Detection at Different Template Concentrations in HIV-1 Phenotypic and Genotypic Tropism Testing
The clinical trials of maraviroc showed that treatment failure was mostly associated with lack of X4 virus detection at baseline. The detection limit for X4 in tropism assays is ill defined around 10%. In the current study, quantification of X4-tropic minority populations was assessed on artificial...
Autores principales: | Vandenbroucke, Ina, Eygen, Veerle Van, Rondelez, Evelien, Vermeiren, Hans, Baelen, Kurt Van, Stuyver, Lieven J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678814/ https://www.ncbi.nlm.nih.gov/pubmed/19440459 http://dx.doi.org/10.2174/1874357900802010008 |
Ejemplares similares
-
HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
por: Vandenbroucke, Ina, et al.
Publicado: (2010) -
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment
por: Vandekerckhove, Linos, et al.
Publicado: (2011) -
Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/Ribavirin
por: Fevery, Bart, et al.
Publicado: (2016) -
Impact of HIV minor species and tropism
por: Metzner, Karin
Publicado: (2012) -
A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay
por: Nauwelaers, David, et al.
Publicado: (2011)